|
CA2700989A1
|
|
Single-use ampoule
|
|
AU2008201113A1
|
|
Recombinant RSV virus expression systems and vaccines
|
|
AU2008200401A1
|
|
Recombinant RSV virus expression systems and vaccines
|
|
CN101578362A
|
|
Influencing viral lipid constituents
|
|
CN101535486A
|
|
A serum-free virus propagation platform for a virus vaccine candidate
|
|
US2008069821A1
|
|
Influenza Hemagglutinin And Neuraminidase Variants
|
|
AU2007201825A1
|
|
Recombinant parainfluenza virus expression systems and vaccines
|
|
CN101297029A
|
|
Methods and compositions for expressing a heterologous protease
|
|
AU2006262380A1
|
|
Methods and compositions for expressing a heterologous protease
|
|
WO2006098901A2
|
|
Influenza hemagglutinin and neuraminidase variants
|
|
AU2006218816A1
|
|
Influenza virus harvester
|
|
AU2006200619A1
|
|
Recombinant RSV virus expression systems and vaccines
|
|
WO2006071563A2
|
|
Non-tumorigenic mdck cell line for propagating viruses
|
|
CN102978169A
|
|
Methods of producing influenza vaccine compositions
|
|
US2006110406A1
|
|
Refrigerator-temperature stable influenza vaccine compositions
|
|
EP1799255A1
|
|
Recombinant human cytomegalovirus and vaccines comprising heterologous antigens
|
|
US2006002862A1
|
|
High pressure spray-dry of bioactive materials
|
|
US2005158340A1
|
|
Recombinant RSV virus expression systems and vaccines
|
|
CA2523657A1
|
|
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
|
WO2004096993A2
|
|
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
